Saxagliptin: A potential doping agent? A randomized, double‐blinded, placebo‐controlled, and crossover pilot study in young active men

Saxagliptin: A potential doping agent? A randomized, double‐blinded, placebo‐controlled, and crossover pilot study in young active men

Abstract Neuropeptide Ys (NPYs) contribute to sympathetic‐adreno stimulation: NPY1‐36 potentiates the effects of catecholamines (CATs), whereas NPY3‐36 inhibits CAT release. We sought to investigate whether inhibiting dipeptidyl‐peptidase‐4 (DPP4), cleaving NPY1‐36 into NPY3‐36, leads to increased N...

Full description

Bibliographic Details
Main Authors: Nicolas Bourdillon, Philippe J. Eugster, Céline Vocat, Toan Nguyen, Gregoire Wuerzner, Eric Grouzmann, Grégoire P. Millet
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Physiological Reports
Subjects:
catecholamines
cycling
DPP4
exercise
neuropeptide Y
performance
Online Access:https://doi.org/10.14814/phy2.15515

Internet

https://doi.org/10.14814/phy2.15515

Similar Items